mlsanityData to 14 Oct 2026

Explainable histomorphology-based survival prediction of glioblastoma, IDH-wildtype

arXiv 2601.11691 ↗First posted 16 Jan 2026eess.IV cs.LG q-bio.QMcited by 0

Not on the map. Why?

Abstract (arXiv)

Glioblastoma, IDH-wildtype (GBM-IDHwt) is the most common malignant brain tumor. While histomorphology is a crucial component of GBM-IDHwt diagnosis, it is not further considered for prognosis. Here, we present an explainable artificial intelligence (AI) framework to identify and interpret histomorphological features associated with patient survival. The framework combines an explainable multiple instance learning (MIL) architecture that directly identifies prognostically relevant image tiles with a sparse autoencoder (SAE) that maps these tiles to interpretable visual patterns. The MIL model was trained and evaluated on a new real-world dataset of 720 GBM-IDHwt cases from three hospitals and four cancer registries across Germany. The SAE was trained on 1,878 whole-slide images from five independent public glioblastoma collections. Despite the many factors influencing survival time, our method showed some ability to discriminate between patients living less than 180 days or more than 360 days solely based on histomorphology (AUC: 0.67; 95% CI: 0.63-0.72). Cox proportional hazards regression confirmed a significant survival difference between predicted groups after adjustment for established prognostic factors (hazard ratio: 1.47; 95% CI: 1.26-1.72). Three neuropathologists categorized the identified visual patterns into seven distinct histomorphological groups, revealing both established prognostic features and unexpected associations, the latter being potentially attributable to surgery-related confounders. The presented explainable AI framework facilitates prognostic biomarker discovery in GBM-IDHwt and beyond, highlighting promising histomorphological features for further analysis and exposing potential confounders that would be hidden in black-box models.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 13 of its 55 references that are in the map. First posted on arXiv 16 Jan 2026.

Builds on

13 of 55 references.

References · 13

  1. 2021TransMIL: Transformer based Correlated Multiple Instance Learning for Whole Slide Image Classificationcited by 555
  2. 2024Scaling and evaluating sparse autoencoderscited by 553
  3. 2020Understanding How Dimension Reduction Tools Work: An Empirical Approach to Deciphering t-SNE, UMAP, TriMAP, and PaCMAP for Data Visualizationcited by 173
  4. 2024Virchow2: Scaling Self-Supervised Mixed Magnification Models in Pathologycited by 161
  5. 2025A Survey on Sparse Autoencoders: Interpreting the Internal Mechanisms of Large Language Modelscited by 76
  6. 2024A Clinical Benchmark of Public Self-Supervised Pathology Foundation Modelscited by 66
  7. 2022Additive MIL: Intrinsically Interpretable Multiple Instance Learning for Pathologycited by 58
  8. 2022Multiple Instance Learning for Digital Pathology: A Review on the State-of-the-Art, Limitations & Future Potentialcited by 54
  9. 2024Benchmarking foundation models as feature extractors for weakly-supervised computational pathologycited by 49
  10. 2025Do Multiple Instance Learning Models Transfer?cited by 29
  11. 2024Learning biologically relevant features in a pathology foundation model using sparse autoencoderscited by 14
  12. 2022Recommendations on test datasets for evaluating AI solutions in pathologycited by 8
1 more
  1. 2023Slideflow: Deep Learning for Digital Histopathology with Real-Time Whole-Slide Visualizationcited by 7

Built on by

Not cited yet.

Similar, not cited

Close in wording, no citation either way

  1. 2026SAGE: Semantic Explainability of Attention-Based Survival Models in Computational Pathology
  2. 2025Computational Imaging Meets LLMs: Zero-Shot IDH Mutation Prediction in Brain Gliomas
  3. 2025IPGPhormer: Interpretable Pathology Graph-Transformer for Survival Analysis
  4. 2024Multiple Instance Learning for Glioma Diagnosis using Hematoxylin and Eosin Whole Slide Images: An Indian Cohort Study
  5. 2026Brain-WM: Brain Glioblastoma World Model
  6. 2026A Vision-Language Foundation Model for Precise and Comprehensive Brain Tumor Diagnosis from Preoperative Multimodal Data
  7. 2026BioFact-MoE: Biologically Factorized Mixture of Experts for Vision-Language Prognostic Modeling in Hepatocellular Carcinoma
  8. 2026Learning Glioblastoma Tumor Heterogeneity Using Brain Inspired Topological Neural Networks